For the quarter ending 2025-09-30, NXTC has $39,613K in assets. $15,967K in debts. $7,324K in cash and cash equivalents.
| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 7,324 | 4,892 | ||
| Marketable securities | 21,786 | 30,416 | ||
| Prepaid expenses and other current assets | 3,530 | 4,707 | ||
| Total current assets | 32,640 | 40,015 | ||
| Property and equipment, net | 3,638 | 4,171 | ||
| Right of use assets | 2,785 | 2,948 | ||
| Other assets | 550 | 555 | ||
| Total assets | 39,613 | 47,689 | ||
| Accounts payable | 2,391 | 2,544 | ||
| Accrued liabilities and other liabilities | 8,604 | 8,237 | ||
| Total current liabilities | 10,995 | 10,781 | ||
| Lease liabilities, long term | 4,411 | 4,666 | ||
| Other long-term liabilities | 561 | 596 | ||
| Total liabilities | 15,967 | 16,043 | ||
| Common stock, par value of 0.001 per share 100,000,000 shares authorized at september 30, 2025 and december 31, 2024 2,676,110 and 2,333,896 shares issued and outstanding at september 30, 2025 and december 31, 2024, respectively | 3 | 2 | ||
| Additional paid-in capital | 450,170 | 447,571 | ||
| Accumulated other comprehensive (loss) income | 17 | -7 | ||
| Accumulated deficit | -426,544 | -417,920 | ||
| Total stockholders' equity | 23,646 | 29,646 | ||
| Common stock, par value of 0.001 per share 100,000,000 shares authorized at june 30, 2025 and december 31, 2024 338,636 and 0 shares issued and outstanding at june 30, 2025 and december 31, 2024, respectively | - | 2,000 | ||
| Total liabilities and stockholders' equity | 39,613 | 47,689 | ||
NextCure, Inc. (NXTC)
NextCure, Inc. (NXTC)